Search company, investor...

Neomics Pharmaceuticals

Founded Year

2022

Stage

Seed | Alive

About Neomics Pharmaceuticals

Neomics Pharmaceuticals focuses on the development of adaptive immune cell products for the treatment of various solid tumors. The company was founded in 2022 and is based in Shanghai, China.

Headquarters Location

Room 1031, 10th Floor, No. 8 Jiafeng Road China (Shanghai) Pilot Free Trade Zone

Shanghai, Shanghai,

China

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo
You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo

Neomics Pharmaceuticals Patents

Neomics Pharmaceuticals has filed 1 patent.

The 3 most popular patent topics include:

  • Clusters of differentiation
  • Immune system
  • Immunology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/4/2022

Clusters of differentiation, Transcription factors, Immunology, Immune system, Proteins

Application

Application Date

1/4/2022

Grant Date

Title

Related Topics

Clusters of differentiation, Transcription factors, Immunology, Immune system, Proteins

Status

Application

Neomics Pharmaceuticals Frequently Asked Questions (FAQ)

  • When was Neomics Pharmaceuticals founded?

    Neomics Pharmaceuticals was founded in 2022.

  • Where is Neomics Pharmaceuticals's headquarters?

    Neomics Pharmaceuticals's headquarters is located at Room 1031, 10th Floor, No. 8 Jiafeng Road, Shanghai.

  • What is Neomics Pharmaceuticals's latest funding round?

    Neomics Pharmaceuticals's latest funding round is Seed.

  • Who are the investors of Neomics Pharmaceuticals?

    Investors of Neomics Pharmaceuticals include Shanghai Biomedical Industry Equity Investment Fund Management.

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.